UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial

Gut, 2006-04, Vol.55 (4), p.505-509

2006

Volltextzugriff (PDF)

Review article: cytomegalovirus and inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2015-04, Vol.41 (8), p.725-733

2015

Volltextzugriff (PDF)

Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2016-03, Vol.43 (5), p.596-611

2016

Volltextzugriff (PDF)

Communication of prostate cancer cells with bone cells via extracellular vesicle RNA; a potential mechanism of metastasis

Oncogene, 2019-03, Vol.38 (10), p.1751-1763

2019

Volltextzugriff (PDF)

Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial

Gut, 2003-07, Vol.52 (7), p.998-1002

2003

Volltextzugriff (PDF)

A pilot study of faecal volatile organic compounds in faeces from cholera patients in Bangladesh to determine their utility in disease diagnosis

Transactions of the Royal Society of Tropical Medicine and Hygiene, 2009-11, Vol.103 (11), p.1171-1173

2009

Volltextzugriff (PDF)

Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study

Gut, 2005-07, Vol.54 (7), p.960-965

2005

Volltextzugriff (PDF)

Chronic pancreatitis biomarkers from urinary volatile organic compounds

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2020-11, Vol.20, p.S91-S91

2020

Volltextzugriff (PDF)

Irritable bowel syndrome and active inflammatory bowel disease diagnosed by faecal gas analysis

Alimentary pharmacology & therapeutics, 2017-01, Vol.45 (1), p.82-90

2017

Volltextzugriff (PDF)

Randomised clinical trial: once‐ vs. twice‐daily prolonged‐release mesalazine for active ulcerative colitis

Alimentary pharmacology & therapeutics, 2013-04, Vol.37 (8), p.767-775

2013

Volltextzugriff (PDF)

Almonds and their impact on gastrointestinal physiology, luminal microbiology and gastrointestinal function: a randomised controlled trial

Proceedings of the Nutrition Society, 2022, Vol.81 (OCE1), Article E17

2022

Volltextzugriff (PDF)

Basiliximab for the treatment of steroid‐resistant ulcerative colitis: further experience in moderate and severe disease

Alimentary pharmacology & therapeutics, 2006-05, Vol.23 (10), p.1435-1442

2006

Volltextzugriff (PDF)

Review article: steroid resistance in inflammatory bowel disease – mechanisms and therapeutic strategies

Alimentary pharmacology & therapeutics, 2007-01, Vol.25 (2), p.111-122

2007

Volltextzugriff (PDF)

Pancreatic cancer biomarker from urinary volatile organic compounds

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2020-11, Vol.20, p.S166-S167

2020

Volltextzugriff (PDF)

Early Use of Azathioprine in Crohn's Disease

Gastroenterology (New York, N.Y. 1943), 2014-03, Vol.146 (3), p.865-866

2014

Volltextzugriff (PDF)

Towards point of care testing for C. difficile infection by volatile profiling, using the combination of a short multi-capillary gas chromatography column with metal oxide sensor detection

Measurement science & technology, 2014-05, Vol.25 (6), p.65108

2014

Volltextzugriff (PDF)

Low FODMAP diet & prebiotic β-galactooligosaccharides improve irritable bowel syndrome and response to low FODMAP is predicted by urine and faecal metabolites: a randomised controlled trial

Proceedings of the Nutrition Society, 2020, Vol.79 (OCE1), Article E19

2020

Volltextzugriff (PDF)

Unique microbial-derived volatile organic compounds in portal venous circulation in murine non-alcoholic fatty liver disease

Biochimica et biophysica acta, 2016-07, Vol.1862 (7), p.1337-1344

2016

Volltextzugriff (PDF)

Letter: faecal volatile organic metabolites, promising biomarkers in inflammatory bowel disease and Letter: faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Authors’ reply

Alimentary pharmacology & therapeutics, 2016-06, Vol.43 (11), p.1241-1242

2016

Volltextzugriff (PDF)

Basiliximab (anti‐CD25) in combination with steroids may be an effective new treatment for steroid‐resistant ulcerative colitis

Alimentary pharmacology & therapeutics, 2003-07, Vol.18 (1), p.65-75

2003

Volltextzugriff (PDF)

Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes

Gut, 1999-09, Vol.45 (3), p.382-388

1999

Volltextzugriff (PDF)

Volatiles from oral anaerobes confounding breath biomarker discovery

Journal of breath research, 2013-03, Vol.7 (1), p.017114-017114

2013

Volltextzugriff (PDF)

A randomized, double‐blind, placebo‐controlled trial of lenalidomide in the treatment of moderately severe active Crohn’s disease

Alimentary Pharmacology and Therapeutics, 2007-08, Vol.26 (3), p.421-430

2007

Volltextzugriff (PDF)

Use of risedronate to prevent bone loss following a single course of glucocorticoids: findings from a proof-of-concept study in inflammatory bowel disease

Osteoporosis international, 2010-03, Vol.21 (3), p.507-513

2010

Volltextzugriff (PDF)

T-cell receptor repertoire in pyoderma gangrenosum: evidence for clonal expansions and trafficking

British journal of dermatology (1951), 2007-11, Vol.157 (5), p.960-966

2007

Volltextzugriff (PDF)

1 – 25 von 914

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(770)
Mit Volltextzugriff
(778)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial

Review article: cytomegalovirus and inflammatory bowel disease

Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease

Communication of prostate cancer cells with bone cells via extracellular vesicle RNA; a potential mechanism of metastasis

Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial

A pilot study of faecal volatile organic compounds in faeces from cholera patients in Bangladesh to determine their utility in disease diagnosis

Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study

Chronic pancreatitis biomarkers from urinary volatile organic compounds

Irritable bowel syndrome and active inflammatory bowel disease diagnosed by faecal gas analysis

Randomised clinical trial: once‐ vs. twice‐daily prolonged‐release mesalazine for active ulcerative colitis

Almonds and their impact on gastrointestinal physiology, luminal microbiology and gastrointestinal function: a randomised controlled trial

Basiliximab for the treatment of steroid‐resistant ulcerative colitis: further experience in moderate and severe disease

Review article: steroid resistance in inflammatory bowel disease – mechanisms and therapeutic strategies

Pancreatic cancer biomarker from urinary volatile organic compounds

Early Use of Azathioprine in Crohn's Disease

Towards point of care testing for C. difficile infection by volatile profiling, using the combination of a short multi-capillary gas chromatography column with metal oxide sensor detection

Low FODMAP diet & prebiotic β-galactooligosaccharides improve irritable bowel syndrome and response to low FODMAP is predicted by urine and faecal metabolites: a randomised controlled trial

Unique microbial-derived volatile organic compounds in portal venous circulation in murine non-alcoholic fatty liver disease

Letter: faecal volatile organic metabolites, promising biomarkers in inflammatory bowel disease and Letter: faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Authors’ reply

Basiliximab (anti‐CD25) in combination with steroids may be an effective new treatment for steroid‐resistant ulcerative colitis

Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes

Volatiles from oral anaerobes confounding breath biomarker discovery

A randomized, double‐blind, placebo‐controlled trial of lenalidomide in the treatment of moderately severe active Crohn’s disease

Use of risedronate to prevent bone loss following a single course of glucocorticoids: findings from a proof-of-concept study in inflammatory bowel disease

T-cell receptor repertoire in pyoderma gangrenosum: evidence for clonal expansions and trafficking

Suchergebnisse filtern